Lv4
558 积分 2023-10-04 加入
[Expert consensus on diagnosis and treatment of advanced non-small cell lung cancer with HER-2 alterations (2025 edition)]
5个月前
已完结
Evaluation of combined pathological responses in primary tumor and lymph nodes following neoadjuvant chemoimmunotherapy in non-small cell lung cancer
9个月前
已完结
Intercostal or Paravertebral Block vs Thoracic Epidural in Lung Surgery
9个月前
已完结
疼痛评估量表应用的中国专家共识（2020版）
10个月前
已完结
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
1年前
已关闭
Improved event-free survival after complete or major pathologic response in patients with resectable NSCLC treated with neoadjuvant chemoimmunotherapy regardless of adjuvant treatment: a systematic review and individual patient data meta-analysis
1年前
已完结
A Response to the Letter to the Editor “Patients With Resectable NSCLC Undergoing Neoadjuvant Chemoimmunotherapy: To Adjuvant or Not to Adjuvant?”
1年前
已关闭
The mutagenic forces shaping the genomes of lung cancer in never smokers
1年前
已完结
Comprehensive Characterization of Somatic Mutation Timing Reveals the Evolutionary Trajectory of Lung Adenocarcinoma in Chinese Patients
1年前
已完结
Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer
1年前
已完结
皖公网安备34019202002308
